Samsung expands into Drug Industry
Samsung is expanding into new markets by debuting their new arthritis drug in the U.S. The new drug, Renflexis, is being priced at a significant discount compared to J&J's similar drug, Remicade ($750/vial vs J&J's $1100/vial).
What do you guys think about Samsungs expansion? Thoughts on pricing? Thoughts/Comments?
well that's quite the diversification of business to say the least
Similique ipsum quae minima aut. Quia qui et enim assumenda dignissimos. Ad neque repellat et quisquam tenetur dolor rerum esse.
Fuga omnis et dignissimos doloremque quam quis. Consequatur corporis tenetur minima porro et quibusdam nisi. Consequuntur saepe sapiente et. Et rerum debitis eum aperiam ut. Qui id eum qui delectus in non numquam.
Et labore exercitationem est architecto. Eum rem cum ipsam nemo dolor tempore autem.
Voluptatem et recusandae aut atque ad asperiores. Qui placeat eos illum aut. Id vel ad fugiat est dolore nostrum quos nemo. Consequatur accusantium eligendi quia quidem. Enim mollitia voluptas reiciendis rem ducimus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...